Neoadjuvant lazertinib with or without chemotherapy for patients with epidermal growth factor receptor (EGFR)-mutated resectable non-small cell lung cancer (NSCLC): NeoLazer trial. This is an ASCO ...
Not open for further replies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results